Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Zhongzhu Medical Holdings Co., Ltd., formerly known as Hubei Qianjiang Pharmaceutical Co., Ltd., was listed on the Shanghai Stock Exchange on May 18, 2001 (stock code: 600568). It is a national ophthalmic drug production base and a listed company in ophthalmic medicine. In recent years, the company has been brave in exploring and continuously practicing in the medical field, and has established a strategic goal of comprehensively advancing towards assisted reproduction, stem cell applications, tumor molecule targeted drugs, tumor diagnosis and treatment equipment, tumor diagnosis and treatment and rehabilitation. Its business covers three major fields: medical, pharmaceutical, and medical equipment. Through the integration of resources, the company has achieved rapid development.
Headquarter Qianjiang
Establish Date 6/27/1994
Listed Code 600568.SH
Listed Date 5/18/2001
Chairman Ye Jige.
CEO Wang Bo.
Website www.zz600568.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial